跳至主要内容
临床试验/EUCTR2016-000141-31-GB
EUCTR2016-000141-31-GB进行中(未招募)1 期

A SERIES OF RANDOMISED CONTROLLED N-of 1 TRIALS IN PATIENTS WHO HAVE DISCONTINUED OR WISH TO DISCONTINUE STATIN USE DUE TO MUSCLE-RELATED SYMPTOMS TO ASSESS IF ATORVASTATIN TREATMENT CAUSES MORE MUSCLE SYMPTOMS THAN PLACEBO - StatinWISE

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 200 人开始时间: 2016年6月29日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Adults (aged 16 and over)
  • Prescribed statin treatment in the last 3 years
  • Stopped OR considering stopping statin treatment due to muscle symptoms
  • Provided fully informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 2
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 98

排除标准

  • Any previously documented serum alanine aminotransferase (ALT) levels at or above three times the upper limit of normal;
  • Have persistent, generalised, unexplained muscle pain (whether associated or not with statin use) and have creatinine kinase (CK) levels greater than 5 times the upper limit of normal
  • Should not be using atorvastatin 20mg daily in the opinion of the general practitioner.

研究者

发起方
ondon School of Hygiene and Tropical Medicine

相似试验